Tom Lemberg

Founder @CurebaseDCT, decentralized clinical trials. Helping any patient, anywhere participate in clinical trials at home and with their own doctor.

[Tom Lemberg @tom_lemberg]

Onward and upward for modern, patient-centric clinical trials. Powered by Curebase.

https://t.co/ZSB9MMVe3w

[TechCrunch @TechCrunch]

Curebase thinks the future of clinical testing is decentralized, and raises $40M to prove it https://t.co/90VjdkwIsI by @techcrunch

[Curebase @CurebaseDCT]

How can we advance health equity in 2022? Curebase founder and CEO, @tom_lemberg, says more #diversity and #patient #access in clinical trials.

Check out his full predictions in : https://t.co/M62qVpSart

[Tom Lemberg @tom_lemberg]

Proud to share our upcoming work in colorectal cancer with great partners.

[Curebase @CurebaseDCT]

We're excited to be partnering with @PersephoneBio and collaborating with @JanssenGlobal on a study to develop prevention strategies and better treatment options for colorectal cancer with a focus on participant #diversity and #access.

https://t.co/SVCpvNpMAH

[Tom Lemberg @tom_lemberg]

Proud to be in good company with @ForbesUnder30 #ForbesUnder30

https://t.co/yshRtg2xrP

[Tom Lemberg @tom_lemberg]

YC Bio Grows!

@ycombinator

https://t.co/z7F0ChsfYZ

[MassDevice @MassDevice]

#Curebase and #CheckableMedical today announced a joint #ClinicalTrial that will assess the efficacy & accuracy of Checkable Medical’s at-home #StrepThroat test kits.

MORE HERE: https://t.co/jgRH1OMjtZ

#SoreThroat #StrepTest #Healthcare @tom_lemberg @CheckableMed @CurebaseDCT

[Tom Lemberg @tom_lemberg]

Proud of our work with @InBiosUSA in securing their COVID-19 rapid test #EUA.

[Curebase @CurebaseDCT]

This summer, we teamed up with @InBiosUSA to secure #EUA for the diagnostic company’s new COVID-19 IgG Antibody Rapid Test - one of many instances where our #DCT model has successfully supported #EUA for diagnostic tests during the pandemic.
https://t.co/gz9VB3ZgVm

[Tom Lemberg @tom_lemberg]

Amazing presentation @ASamson_DCTs!

[Curebase @CurebaseDCT]

We hope you were able to see Adam Samson, our Senior Director of ClinOps & Customer Success, present at #DTxEast2021 on long-term retention and monitoring in #patient outcomes in #DTx trials. Book a meeting with our team to learn more about #DCT in #DTx. https://t.co/gU9zrwLIym

[Tom Lemberg @tom_lemberg]

Chatting on Clubhouse with the Gene Fixers @eperlste and Julia Vitarello Thursday at 2pm PT / 5pm ET.

Come see how decentralized trials and telemedicine intersect with rare disease.

https://t.co/L43cquh6qA

[Tom Lemberg @tom_lemberg]

Excited to be powering VR clinical trials with @AppliedVR.

Thanks for covering @ky_lahucik.

#virtualreality #clinicaltrial

https://t.co/7seQDHewzI

[Tom Lemberg @tom_lemberg]

Immune Medicine + Decentralized Clinical Trials.

#DCT #diagnostics #clinicaltrials

https://t.co/WDCn3ZDNFq

[Science in Seattle @science_seattle]

🗞️ @AdaptiveBiotech and @CurebaseDCT have announced a research collaboration to broaden patient participation in Adaptive's clinical studies. Their initial study will validate the effectiveness of Adaptive's #LymeDisease immune detection test.

PR: https://t.co/g4Rey7XMy1

[Tom Lemberg @tom_lemberg]

Announcing our research collaboration with
@AdaptiveBiotech
! Brining DCTs to immune medicine.

First projects together:
- T-Detect™ for patients with Lyme disease
- COVID-19 long-term data study

#decentralized #clinicaltrials

https://t.co/A1LtR7UVL7

[Tom Lemberg @tom_lemberg]

Keep it going @alixaman !

[Ali Zaman @alixaman]

6 months ago I left my job to start a company to help people with Parkinson's disease.

Today, we got our first paid subscriber 😃

[Tom Lemberg @tom_lemberg]

Bring your own Physician (BYOP) is our solution to bringing high-impact clinical trial options to every patient with their own doctors.

Thanks @DrugDiscoveryLR for covering Curebase.

https://t.co/auIv0ydc67

[Tom Lemberg @tom_lemberg]

My thoughts shared in WSJ: It's time to raise funding, be ambitious, and move fast if you're a digital health startup in 2021.

https://t.co/uK0QFB7HAQ

[Tom Lemberg @tom_lemberg]

Read about Curebase, DCTs, and the effect of COVID-19 on clinical trials in Forbes.

Thanks @Rychlewski2!

https://t.co/01g8CiXBe8

[Tom Lemberg @tom_lemberg]

The Amgen approval is exciting. Pill-based, targeted cancer therapy for KRAS lung cancer patients.

https://t.co/oabzYlI40w

[Tom Lemberg @tom_lemberg]

Spent 30 minutes sharing my founder story on #unscripted w/
@jrichlive.

https://t.co/L9NUnMrYkS